109 related articles for article (PubMed ID: 21666987)
1. Comorbidity, use of common medications, and risk of early death in patients with localized or locally advanced prostate cancer.
Nieder C; Dalhaug A; Pawinski A; Aandahl G; Norum J
ScientificWorldJournal; 2011 Jun; 11():1178-86. PubMed ID: 21666987
[TBL] [Abstract][Full Text] [Related]
2. Impact of Charlson comorbidity index varies by age in patients with prostate cancer treated by radical prostatectomy: a competing risk regression analysis.
Lee JY; Lee DH; Cho NH; Rha KH; Choi YD; Hong SJ; Yang SC; Cho KS
Ann Surg Oncol; 2014 Feb; 21(2):677-83. PubMed ID: 24145996
[TBL] [Abstract][Full Text] [Related]
3. Prediction of mortality after radical prostatectomy by Charlson comorbidity index.
Guzzo TJ; Dluzniewski P; Orosco R; Platz EA; Partin AW; Han M
Urology; 2010 Sep; 76(3):553-7. PubMed ID: 20627284
[TBL] [Abstract][Full Text] [Related]
4. Charlson Comorbidity Index is a predictor of outcomes in incident hemodialysis patients and correlates with phase angle and hospitalization.
Di Iorio B; Cillo N; Cirillo M; De Santo NG
Int J Artif Organs; 2004 Apr; 27(4):330-6. PubMed ID: 15163067
[TBL] [Abstract][Full Text] [Related]
5. Impact of comorbidity on treatment and prognosis of prostate cancer patients: a population-based study.
Houterman S; Janssen-Heijnen ML; Hendrikx AJ; van den Berg HA; Coebergh JW
Crit Rev Oncol Hematol; 2006 Apr; 58(1):60-7. PubMed ID: 16213153
[TBL] [Abstract][Full Text] [Related]
6. Hormonal therapy use for prostate cancer and mortality in men with coronary artery disease-induced congestive heart failure or myocardial infarction.
Nanda A; Chen MH; Braccioforte MH; Moran BJ; D'Amico AV
JAMA; 2009 Aug; 302(8):866-73. PubMed ID: 19706860
[TBL] [Abstract][Full Text] [Related]
7. Age-adjusted Charlson Comorbidity Index as effective predictor for in-hospital mortality of patients with cardiac arrest: a retrospective study.
Zhang N; Lin Q; Jiang H; Zhu H
BMC Emerg Med; 2023 Jan; 23(1):7. PubMed ID: 36703122
[TBL] [Abstract][Full Text] [Related]
8. Charlson Comorbidity score influence on prostate cancer survival and radiation-related toxicity.
Ghanem AI; Khalil RM; Khedr GA; Tang A; Elsaid AA; Chetty IJ; Movsas B; Elshaikh MA
Can J Urol; 2020 Apr; 27(2):10154-10161. PubMed ID: 32333734
[TBL] [Abstract][Full Text] [Related]
9. [Risk factors associated with mortality in patient with non-high-risk pulmonary embolism and cancer and the prognostic value of Charlson comorbidity index].
Zhou C; Wang YX; Zhong X; Yang ZH; Zhang M; Zhou HX; Yi Q
Zhonghua Yi Xue Za Zhi; 2020 Aug; 100(30):2383-2387. PubMed ID: 32791816
[No Abstract] [Full Text] [Related]
10. Use of the Charlson combined comorbidity index to predict postradiotherapy quality of life for prostate cancer patients.
Wahlgren T; Levitt S; Kowalski J; Nilsson S; Brandberg Y
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):997-1004. PubMed ID: 20932681
[TBL] [Abstract][Full Text] [Related]
11. The age-adjusted Charlson Comorbidity Index as an outcome predictor of patients with acute mesenteric ischemia.
Marchena-Gomez J; Acosta-Merida MA; Hemmersbach-Miller M; Conde-Martel A; Roque-Castellano C; Hernandez-Romero J
Ann Vasc Surg; 2009; 23(4):458-64. PubMed ID: 19128926
[TBL] [Abstract][Full Text] [Related]
12. The need for androgen deprivation therapy in patients with intermediate-risk prostate cancer treated with dose-escalated external beam radiation therapy.
Dong Y; Ruth KJ; Churilla TM; Viterbo R; Sobczak ML; Smaldone MC; Chen DY; Uzzo RG; Hallman MH; Horwitz EM
Can J Urol; 2017 Feb; 24(1):8656-8662. PubMed ID: 28263132
[TBL] [Abstract][Full Text] [Related]
13. Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial.
Denham JW; Joseph D; Lamb DS; Spry NA; Duchesne G; Matthews J; Atkinson C; Tai KH; Christie D; Kenny L; Turner S; Gogna NK; Diamond T; Delahunt B; Oldmeadow C; Attia J; Steigler A
Lancet Oncol; 2019 Feb; 20(2):267-281. PubMed ID: 30579763
[TBL] [Abstract][Full Text] [Related]
14. Impact of age and comorbidities on long-term survival of patients with high-risk prostate cancer treated with radical prostatectomy: a multi-institutional competing-risks analysis.
Briganti A; Spahn M; Joniau S; Gontero P; Bianchi M; Kneitz B; Chun FK; Sun M; Graefen M; Abdollah F; Marchioro G; Frohenberg D; Giona S; Frea B; Karakiewicz PI; Montorsi F; Van Poppel H; Jeffrey Karnes R;
Eur Urol; 2013 Apr; 63(4):693-701. PubMed ID: 22959192
[TBL] [Abstract][Full Text] [Related]
15. The risk-adjusted Charlson comorbidity index as a new predictor of one-year mortality rate in elderly Chinese patients who underwent hip fracture surgery.
Xing F; Luo R; Chen W; Zhou X
Orthop Traumatol Surg Res; 2021 May; 107(3):102860. PubMed ID: 33609760
[TBL] [Abstract][Full Text] [Related]
16. Survival Outcomes in Octogenarian and Nonagenarian Patients Treated with First-line Androgen Deprivation Therapy for Organ-confined Prostate Cancer.
Dell'Oglio P; Bishr M; Boehm K; Trudeau V; Larcher A; Tian Z; Sosa J; Moschini M; Saad F; Capitanio U; Briganti A; Graefen M; Montorsi F; Karakiewicz PI
Eur Urol Focus; 2018 Dec; 4(6):834-841. PubMed ID: 28753853
[TBL] [Abstract][Full Text] [Related]
17. Assessing the impact of comorbid illnesses on death within 10 years in prostate cancer treatment candidates.
Groome PA; Rohland SL; Siemens DR; Brundage MD; Heaton J; Mackillop WJ
Cancer; 2011 Sep; 117(17):3943-52. PubMed ID: 21858801
[TBL] [Abstract][Full Text] [Related]
18. Comorbidity and age cannot explain variation in life expectancy associated with treatment of non-metastatic prostate cancer.
Boehm K; Dell'Oglio P; Tian Z; Capitanio U; Chun FKH; Tilki D; Haferkamp A; Saad F; Montorsi F; Graefen M; Karakiewicz PI
World J Urol; 2017 Jul; 35(7):1031-1036. PubMed ID: 27796538
[TBL] [Abstract][Full Text] [Related]
19. Is the Charlson Comorbidity Index a Prognostic Indicator for Toxicity and Mortality in Elderly Patients with Locally Advanced Rectal Cancer?
Köstek O; Bozkaya Y; Hacıoğlu MB; Yıldırım Özdemir N; Yılmaz E; Demircan NC; Erdoğan B; Uzunoğlu S; Çiçin İ; Zengin N
Arch Iran Med; 2019 May; 22(5):236-241. PubMed ID: 31256595
[TBL] [Abstract][Full Text] [Related]
20. [Risk factors associated with long-term mortality in patients with pulmonary embolism and the predictive value of Charlson comorbidity index].
Zhou H; Tang Y; Wang L; Shi C; Feng Y; Yi Q
Zhonghua Yi Xue Za Zhi; 2016 Jan; 96(4):273-6. PubMed ID: 26879787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
